In highly aggressive cancer types, common phenotypes include the loss of wild-type p53, which could explain the observed correlation between cancer aggressiveness and the difference in FUCA1 expression in ATCs that are derived from more differentiated PTCs [158]. This evidence concerns the gene TP53 and cancer.